Not all patients with CLL have to have therapy. Regardless of all recent advances, the iwCLL nonetheless endorses watchful observation for people with asymptomatic disorder.86 This recommendation is based on a minimum of two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). adalah situs https://williamg332tjy8.wikinewspaper.com/user